PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 154 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $15,000 | +400.0% | 2,988 | +453.3% | 0.00% | – |
| Q3 2019 | $3,000 | -25.0% | 540 | -10.0% | 0.00% | – |
| Q2 2019 | $4,000 | +100.0% | 600 | +19.0% | 0.00% | – |
| Q1 2019 | $2,000 | -97.4% | 504 | -94.8% | 0.00% | -100.0% |
| Q2 2018 | $78,000 | +105.3% | 9,656 | +140.0% | 0.01% | +25.0% |
| Q1 2017 | $38,000 | -13.6% | 4,023 | -21.1% | 0.00% | -20.0% |
| Q4 2016 | $44,000 | -17.0% | 5,100 | -44.8% | 0.01% | -37.5% |
| Q3 2015 | $53,000 | -26.4% | 9,239 | -4.8% | 0.01% | -20.0% |
| Q2 2015 | $72,000 | -14.3% | 9,700 | -30.7% | 0.01% | -16.7% |
| Q1 2015 | $84,000 | -46.5% | 14,000 | -32.7% | 0.01% | -47.8% |
| Q4 2014 | $157,000 | +1021.4% | 20,800 | +494.3% | 0.02% | +1050.0% |
| Q1 2014 | $14,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 1,255,000 | $5,823,000 | 1.12% |
| Phocas Financial Corp. | 1,146,292 | $5,319,000 | 0.54% |
| Worth Venture Partners, LLC | 138,357 | $641,000 | 0.36% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,293,179 | $10,640,000 | 0.34% |
| Monashee Investment Management LLC | 240,000 | $1,114,000 | 0.26% |
| BKS ADVISORS, LLC | 118,587 | $550,000 | 0.22% |
| PINNACLE ASSOCIATES LTD | 1,418,391 | $6,581,000 | 0.15% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,200,820 | $19,492,000 | 0.15% |
| Fosun International Ltd | 472,580 | $2,174,000 | 0.14% |
| CARILLON TOWER ADVISERS, INC. | 3,948,024 | $18,318,000 | 0.13% |